XTL Biopharmaceuticals Ltd (H2K2) — Tangible Net Worth Ratio
XTL Biopharmaceuticals Ltd (H2K2) has a Tangible Net Worth Ratio of 29.8% as of December 2024. This metric is calculated by deducting intangible assets (€3.82 Million) from net assets (€5.43 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See XTL Biopharmaceuticals Ltd (H2K2) shareholders funds for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
XTL Biopharmaceuticals Ltd Tangible Net Worth Ratio (2016–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of December 2024, the ratio stands at 29.8%, reflecting net assets of €5.43 Million with intangible assets of €3.82 Million EUR. Also explore net asset growth rate of XTL Biopharmaceuticals Ltd to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see XTL Biopharmaceuticals Ltd (H2K2) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 29.8% | €5.43 Million | €3.82 Million | €8.55 Million | ▼ -53.1 pp |
| 2023 | 82.9% | €2.22 Million | €380.00K | €2.43 Million | ▼ -7.6 pp |
| 2022 | 90.5% | €4.00 Million | €380.00K | €4.19 Million | ▼ -2.4 pp |
| 2021 | 92.9% | €5.33 Million | €380.00K | €6.62 Million | ▼ -1.0 pp |
| 2020 | 93.9% | €6.25 Million | €380.00K | €6.50 Million | ▼ -0.6 pp |
| 2019 | 94.6% | €6.98 Million | €380.00K | €7.21 Million | ▼ -0.9 pp |
| 2018 | 95.4% | €8.32 Million | €380.00K | €8.57 Million | ▲ +5.9 pp |
| 2017 | 89.5% | €3.62 Million | €380.00K | €6.59 Million | ▼ -1.1 pp |
| 2016 | 90.6% | €2.69 Million | €253.00K | €3.02 Million | — |